Advances in cortical modulation of pain

Journal of Pain Research

Volumn 6, Issue , 2013, Pages 713-725

  Quintero, Gabriel C ^a,b  

^a FLORIDA STATE UNIVERSITY   (United States)

^b SMITHSONIAN TROPICAL RESEARCH INSTITUTE   (Panama)

Author keywords

Cingulate cortex; Glia; Glutamate; Insular cortex; Pain; Somatosensory cortex

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 2,10,11 TRIHYDROXY N PROPYLNORAPORPHINE HYDROBROMIDE; 4 AMINOBUTYRIC ACID; 4 BENZYL ALPHA (4 HYDROXYPHENYL) BETA METHYL 1 PIPERIDINEPROPANOL; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ADENYLATE CYCLASE; ADENYLATE CYCLASE INHIBITOR; ADRENALIN; APOMORPHINE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CYTOKINE; DOPAMINE; DOPAMINE 2 RECEPTOR STIMULATING AGENT; GLUTAMIC ACID; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; LIDOCAINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NALOXONE; NB 001; OPIATE; PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 38; PROTEIN KINASE; RACLOPRIDE; RO 63 1908; UNCLASSIFIED DRUG;

ANTERIOR CINGULATE; ASTROCYTE; BRAIN CORTEX; BRAIN DEPTH STIMULATION; BRAIN FUNCTION; DNA METHYLATION; ESOPHAGUS PAIN; FOREBRAIN; GLIA CELL; INFLAMMATION; INFLAMMATORY PAIN; INSULA; MACROGLIA; MICROGLIA; MOTOR CORTEX; NEUROMODULATION; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; OCCIPITAL CORTEX; ORBITAL CORTEX; PAIN; PREFRONTAL CORTEX; RETROSPLENIAL CORTEX; REVIEW; SOMATOSENSORY CORTEX; SYNAPSE;

EID: 84884720852     PISSN: 11787090     EISSN: None     Source Type: Journal    
DOI: 10.2147/JPR.S45958     Document Type: Review

References (101)

1. Zhuo M. Cortical excitation and chronic pain. Trends Neurosci. 2008;31(4):199-207.
2. Xie YF, Huo FQ, Tang JS. Cerebral cortex modulation of pain. Acta Pharmacol Sin. 2009;30(1):31-41.
3. Millan MJ. Descending control of pain. Prog Neurobiol. 2002;66(6): 355-474.
4. Ossipov MH, Dussor GO, Porreca F. Central modulation of pain. J Clin Invest. 2010;120(11):3779-3787.
5. Fields HL, Basbaum AI, Heinricher MM. Central nervous system mechanisms of pain modulation. In McMahon S, Koltzenburg M, editors. Wall and Melzack's Textbook of Pain. 5th ed. Philadelphia: Churchill Livingstone; 2005:125-142.
6. Akil H, Mayer DJ, Liebeskind JC. Antagonism of stimulation-produced analgesia by naloxone, a narcotic antagonist. Science. 1976;191(4230): 961-962.
7. Basbaumm AI, Clanton CH, Fields HL. Opiate and stimulus-produced analgesia: functional anatomy of a medullospinal pathway. Proc Natl Acad Sci U S A. 1976;73(12):4685-4688.
8. Basbaum AI, Clantonm CH, Fields HL. Three bulbospinal pathways from the rostral medulla of the cat: an autoradiographic study of pain modulating systems. J Comp Neurol. 1978;178(2):209-224.
9. Abols IA, Basbaum AI. Afferent connections of the rostral medulla of the cat: a neural substrate for midbrain-medullary interactions in the modulation of pain. J Comp Neurol. 1981;201(2):285-297.
10. Glazer EJ, Basbaum AI. Immunohistochemical localization of leucine-enkephalin in the spinal cord of the cat: enkephalin-containing marginal neurons and pain modulation. J Comp Neurol. 1981;196(3):377-389.
11. Basbaum AI. Descending control of pain transmission: possible serotonergic-enkephalinergic interactions. Adv Exp Med Biol. 1981;133: 177-189.
12. Basbaum AI, Fields HL. Endogenous pain control mechanisms: review and hypothesis. Ann Neurol. 1978;4(5):451-462.
13. Cui M, Feng Y, McAdoo DJ, Willis WD. Periaqueductal gray stimulation-induced inhibition of nociceptive dorsal horn neurons in rats is associated with the release of norepinephrine, serotonin, and amino acids. J Pharmacol Exp Ther. 1999;289(2):868-876.
14. Decety J, Jackson PL. The functional architecture of human empathy. Behav Cogn Neurosci Rev. 2004;3(2):71-100.
15. Jackson PL, Brunet E, Meltzoff AN, Decety J. Empathy examined through the neural mechanisms involved in imagining how I feel versus how you feel pain. Neuropsychologia. 2006;44(5):752-761.
16. Wang H, Xu H, Wu LJ, etal. Identification of an adenylyl cyclase inhibitor for treating neuropathic and inflammatory pain. Sci Transl Med. 2011;3(65):65ra63.
17. Koga K, Li X, Chen T, Steenland HW, Descalzi G, Zhuo M. In vivo whole-cell patch-clamp recording of sensory synaptic responses of cingulate pyramidal neurons to noxious mechanical stimuli in adult mice. Mol Pain. 2010;6:62.
18. Qu C, King T, Okun A, Lai J, Fields HL, Porreca F. Lesion of the rostral anterior cingulate cortex eliminates the aversiveness of spontaneous neuropathic pain following partial or complete axotomy. Pain. 2011;152(7):1641-1648.
19. Johansen JP, Fields HL, Manning BH. The affective component of pain in rodents: direct evidence for a contribution of the anterior cingulate cortex. Proc Natl Acad Sci U S A. 2001;98(14):8077-8082.
20. Kim SS, Descalzi G, Zhuo M. Investigation of molecular mechanism of chronic pain in the anterior cingulate cortex using genetically engineered mice. Curr Genomics. 2010;11(1):70-76.
21. Wei F, Qiu CS, Kim SJ, etal. Genetic elimination of behavioral sensitization in mice lacking calmodulin-stimulated adenylyl cyclases. Neuron. 2002;36(4):713-726.
22. Lu Y, Zhu L, Gao YJ. Pain-related aversion induces astrocytic reaction and proinflammatory cytokine expression in the anterior cingulate cortex in rats. Brain Res Bull. 2011;84(2):178-182.
23. Wei F, Wang GD, Kerchner GA, etal. Genetic enhancement of inflammatory pain by forebrain NR2B overexpression. Nat Neurosci. 2001;4(2):164-169.
24. Wu LJ, Toyoda H, Zhao MG, etal. Upregulation of forebrain NMDA NR2B receptors contributes to behavioral sensitization after inflammation. J Neurosci. 2005;25(48):11107-11116.
25. Quintero GC, Herrera J, Bethancourt J. Cortical NR2B NMDA subunit antagonism reduces inflammatory pain in male and female rats. J Pain Res. 2011;4:301-308.
26. Li XY, Ko HG, Chen T, etal. Alleviating neuropathic pain hypersensitivity by inhibiting PKMzeta in the anterior cingulate cortex. Science. 2010;330(6009):1400-1404.
27. Li XY, Ko HG, Chen T, Collingridge GL, Kaang BK, Zhuo M. Erasing injury-related cortical synaptic potentiation as a new treatment for chronic pain. J Mol Med (Berl). 2011;89(9):847-855.
28. Ling D, Benardo L, Serrano P, etal. Protein kinase Mzeta is necessary and sufficient for LTP maintenance. Nat Neurosci. 2002;5(4):295-296.
29. Serrano P, Yao Y, Sacktor TC. Persistent phosphorylation by protein kinase Mzeta maintains late-phase long-term potentiation. J Neurosci. 2005;25(8):1979-1984.
30. Hernandez AL, Blace N, Crary JF, etal. Protein kinase M zeta synthesis from a brain mRNA encoding an independent protein kinase C zeta catalytic domain. Implications for the molecular mechanism of memory. J Biol Chem. 2003;278(41):40305-40316.
31. Volk LJ, Bachman JL, Johnson R, Yu Y, Huganir RL. PKM-ζ is not required for hippocampal synaptic plasticity, learning and memory. Nature. 2013;493(7432):420-423.
32. Lee AM, Kanter BR, Wang D, etal. Prkcz null mice show normal learning and memory. Nature. 2013;493(7432):416-419.
33. Price TJ, Ghosh S. ZIPping to pain relief: the role (or not) of PKMζ in chronic pain. Mol Pain. 2013;9:6.
34. Toyoda H, Zhao MG, Zhuo M. Enhanced quantal release of excitatory transmitter in anterior cingulate cortex of adult mice with chronic pain. Mol Pain. 2009;5:4.
35. Banerjee B, Medda BK, Schmidt J, Lang IM, Sengupta JN, Shaker R. Neuronal plasticity in the cingulate cortex of rats following esophageal acid exposure in early life. Gastroenterology. 2011;141(2):544-552.
36. Wei F, Wang GD, Zhang C, etal. Forebrain overexpression of CaMKII abolishes cingulate long term depression and reduces mechanical allodynia and thermal hyperalgesia. Mol Pain. 2006;2:21.
37. Wang H, Shimizu E, Tang YP, etal. Inducible protein knockout reveals temporal requirement of CaMKII reactivation for memory consolidation in the brain. Proc Natl Acad Sci U S A. 2003;100(7): 4287-4292.
38. Strack S, Choi S, Lovinger DM, Colbran RJ. Translocation of autophosphorylated calcium/calmodulin-dependent protein kinase ii to the postsynaptic density. J Biol Chem. 1997;272(2):13467-13470.
39. Benke TA, Lüthi A, Isaac JT, Collingridge GL. Modulation of AMPA receptor unitary conductance by synaptic activity. Nature. 1998; 393(6687):793-797.
40. Baliki MN, Geha PY, Apkarian AV. Parsing pain perception between nociceptive representation and magnitude estimation. J Neurophysiol. 2009;101(2):875-887.
41. Ogino Y, Nemoto H, Inui K, Saito S, Kakigi R, Goto F. Inner experience of pain: imagination of pain while viewing images showing painful events forms subjective pain representation in human brain. Cereb Cortex. 2007;17(5):1139-1146.
42. Burkey AR, Carstens E, Wenniger JJ, etal. An opioidergic cortical antinociception triggering site in the agranular insular cortex of the rat that contributes to morphine antinociception. J Neurosci. 1996;16(20): 6612-6623.
43. Jasmin L, Rabkin SD, Granato A, Boudah A, Ohara PT. Analgesia and hyperalgesia from GABA-mediated modulation of the cerebral cortex. Nature. 2003;424(6946):316-320.
44. Coffeen U, Lopez-Avila A, Ortega-Legaspi JM, del Angel R, López-Muñoz FJ, Pellicer F. Dopamine receptors in the anterior insular cortex modulate long-term nociception in the rat. Eur J Pain. 2008;12(5):535-543.
45. Willoch F, Schindler F, Wester HJ, etal. Central poststroke pain and reduced opioid receptor binding within pain processing circuitries: a [11C]diprenorphine PET study. Pain. 2004;108(3):213-220.
46. Zubieta JK, Smith YR, Bueller JA, etal. Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science. 2001;293(5528):311-315.
47. Xie YF, Wang J, Huo FQ, etal. Mu but not delta and kappa opioid receptor involvement in ventrolateral orbital cortex opioid-evoked antinociception in formalin test rats. Neuroscience. 2004;126(3): 717-726.
48. Maarrawi J, Peyron R, Mertens P, etal. Differential brain opioid receptor availability in central and peripheral neuropathic pain. Pain. 2007;127(1-2):183-194.
49. Burkey AR, Carstens E, Jasmin L. Dopamine reuptake inhibition in the rostral agranular insular cortex produces antinociception. J Neurosci. 1999;19(10):4169-4179.
50. Jasmin L, Burkey AR, Granato A, Ohara PT. Rostral agranular insular cortex and pain areas of the central nervous system: a tract-tracing study in the rat. J Comp Neurol. 2004;468(3):425-440.
51. Tranel D. "Acquired sociopathy": the development of sociopathic behavior following focal brain damage. Prog Exp Pers Psychopathol Res. 1994:285-311.
52. Treede RD, Kenshalo DR, Gracely RH, Jones AK. The cortical representation of pain. Pain. 1999;79(2-3):105-111.
53. Snow PJ, Lumb BM, Cervero F. The representation of prolonged and intense, noxious somatic and visceral stimuli in the ventrolateral orbital cortex of the cat. Pain. 1992;48(1):89-99.
54. Zhang YQ, Tang JS, Yuan B, Jia H. Inhibitory effects of electrically evoked activation of ventrolateral orbital cortex on the tail-flick reflex are mediated by periaqueductal gray in rats. Pain. 1997;72(1-2): 127-135.
55. Dang YH, Xing B, Zhao Y, etal. The role of dopamine receptors in ventrolateral orbital cortex-evoked antinociception in a rat formalin test model. Eur J Pharmacol. 2011;657(1-3):97-103.
56. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. Dopamine receptors: from structure to function. Physiol Rev. 1998;78(1):189-225.
57. Vallone D, Oicetti R, Borrelli E. Structure and function of dopamine receptors. Neurosci Biobehav Rev. 2000;24(1):125-132.
58. Cooper SJ. Anaesthetisation of prefrontal cortex and response to noxious stimulation. Nature. 1975;254(5499):439-440.
59. Zhang S, Tang JS, Yuan B, Jia H. Inhibitory effects of electrical stimulation of ventrolateral orbital cortex on the rat jaw-opening reflex. Brain Res. 1998;813(2):359-366.
60. Baliki M, Al-Amin HA, Atweh SF, etal. Attenuation of neuropathic manifestations by local block of the activities of the ventrolateral orbito-frontal area in the rat. Neuroscience. 2003;120(4):1093-1104.
61. Heinricher MM, Morgan MM, Tortorici V, Fields HL. Disinhibition of off-cells and antinociception produced by an opioid action within the rostral ventromedial medulla. Neuroscience. 1994;63(1):279-288.
62. Paxinos G. The Rat Nervous System. 2nd ed. San Diego: Academic Press; 1995.
63. Shibasaki H. Central mechanisms of pain perception. Suppl Clin Neurophysiol. 2004;57:39-49.
64. Sewards TV, Sewards M. Separate, parallel sensory and hedonic pathways in the mammalian somatosensory system. Brain Res Bull. 2002;58(3):243-260.
65. Kuroda R, Kawao N, Yoshimura H, etal. Secondary somatosensory cortex stimulation facilitates the antinociceptive effect of the NO synthase inhibitor through suppression of spinal nociceptive neurons in the rat. Brain Res. 2001;903(1-2):110-116.
66. Gojyo F, Sugiyo S, Kuroda R, etal. Effects of somatosensory cortical stimulation on expression of c-Fos in rat medullary dorsal horn in response to formalin-induced noxious stimulation. J Neurosci Res. 2002;68(4):479-488.
67. Neto FL, Schadrack J, Platzer S, Zieglgänsberger W, Tölle TR, Castro-Lopes JM. Up-regulation of metabotropic glutamate receptor 3 mRNA expression in the cerebral cortex of monoarthritic rats. J Neurosci Res. 2001;63(4):356-367.
68. Villalba MBJ, Journot L. Pituitary adenylate cyclase-activating polypeptide (PACAP-38) protects cerebellar granule neurons from apoptosis by activating the mitogen activated protein kinase (MAP kinase) pathway. J Neurosci. 1997;17(1):83-90.
69. Sandor K, Kormos V, Botz B, etal. Impaired nocifensive behaviours and mechanical hyperalgesia, but enhanced thermal allodynia in pituitary adenylate cyclase-activating polypeptide deficient mice. Neuropeptides. 2010;44(5):363-371.
70. Rang HP, Ritter JM, Flower RJ. Noradrenergic transmission. In: Rang and Dale's Pharmacology. 6th ed. Philadelphia: Churchill Livingstone; 2007:169-170.
71. Nalepa I, Vetulani J, Borghi V, etal. Changes induced by formalin pain in central alpha1-adrenoceptor density are modulated by adenosine receptor agonists. J Neural Transm. 2010;117(5):549-558.
72. Reis GM, Dias QM, Silveira JW, Del Vecchio F, Garcia-Cairasco N, Prado WA. Antinociceptive effect of stimulating the occipital or retrosplenial cortex in rats. J Pain. 2010;11(10):1015-1026.
73. Vann SD, Aggleton JP, Maguire EA. What does the retrosplenial cortex do? Nat Rev Neurosci. 2009;10(11):792-802.
74. Sanes JN. Primary motor cortex. In: Weiner IB, Craighead WE. The Corsini Encyclopedia of Psychology. Hoboken (NJ): Wiley; 2010.
75. Pagano RL, Fonoff ET, Dale CS, Ballester G, Teixeira MJ, Britto LR. Motor cortex stimulation inhibits thalamic sensory neurons and enhances activity of PAG neurons: possible pathways for antinociception. Pain. 2012;153(12):2359-2369.
76. Pagano RL, Assis DV, Clara JA, etal. Transdural motor cortex stimulation reverses neuropathic pain in rats: a profile of neuronal activation. Eur J Pain. 2011;15(3):268. e1-e14.
77. Tajerian M, Alvarado S, Millecamps M, etal. Peripheral nerve injury is associated with chronic, reversible changes in global DNA methylation in the mouse prefrontal cortex. PLoS One. 2013;8(1):e55259.
78. Jessen K, Mirsky R. Glial cells in the enteric nervous system contain glial fibrillary acidic protein. Nature. 1980;(286):736-737.
79. Xie YF, Zhang S, Chiang CY, Hu JW, Dostrovsky JO, Sessle BJ. Involvement of glia in central sensitization in trigeminal subnucleus caudalis (medullary dorsal horn). Brain Behav Immun. 2007;21(5): 634-641.
80. Kuzumaki N, Narita M, Hareyama N, etal. Chronic pain-induced astrocyte activation in the cingulate cortex with no change in neural or glial differentiation from neural stem cells in mice. Neurosci Lett. 2007;415(1):22-27.
81. Narita M, Kuzumaki N, Kaneko C, etal. Chronic pain-induced emotional dysfunction is associated with astrogliosis due to cortical delta-opioid receptor dysfunction. J Neurochem. 2006;97(5):1369-1378.
82. Watkins L, Maier S. Glia and pain: past, present, and future. In: Merskey H, Loeser JD, Dubner R, editors. The Paths of Pain: 1975-2005. Washington: IASP Press; 2005.
83. Wieseler-Frank J, Maier SF, Watkins LR. Glial activation and pathological pain. Neurochem Int. 2004;45(2-3):389-395.
84. Zhuo M, Wu G, Wu LJ. Neuronal and microglial mechanisms of neuropathic pain. Mol Brain. 2011;4:31.
85. Tsuda M, Inoue K, Salter MW. Neuropathic pain and spinal microglia: a big problem from molecules in "small" glia. Trends Neurosci. 2005;28(2):101-107.
86. González-Scarano F, Baltuch G. Microglia as mediators of inflammatory and degenerative diseases. Ann Rev Neurosci. 1999;22: 219-240.
87. Bruce-Keller AJ. Microglial-neuronal interactions in synaptic damage and recovery. J Neurosci Res. 1999;58(1):191-201.
88. Ji RR, Suter MR. p38 MAPK, microglial signaling, and neuropathic pain. Mol Pain. 2007;3:33.
89. Gosselin RD, Suter MR, Ji RR, Decosterd I. Glial cells and chronic pain. Neuroscientist. 2010;16(5):519-531.
90. Zhang F, Vadakkan KI, Kim SS, Wu LJ, Shang Y, Zhuo M. Selective activation of microglia in spinal cord but not higher cortical regions following nerve injury in adult mouse. Mol Pain. 2008;4:15.
91. Giordano C, Cristino L, Luongo L, etal. TRPV1-dependent and-independent alterations in the limbic cortex of neuropathic mice: impact on glial caspases and pain perception. Cereb Cortex. 2012;22(11):2495-2518.
92. Liauw J, Wu LJ, Zhuo M. Calcium-stimulated adenylyl cyclases required for long-term potentiation in the anterior cingulate cortex. J Neurophysiol. 2005;94(1):878-882.
93. Zhuo M. Central plasticity in pathological pain. Novartis Found Symp. 2004;261:132-145; discussion 145-154.
94. Zhuo M. Targeting neuronal adenylyl cyclase for the treatment of chronic pain. Drug Discov Today. 2012;17(11-12):573-582.
95. Mogil JS, Bailey AL. Sex and gender differences in pain and analgesia. Prog Brain Res. 2010;186:141-157.
96. Greenspan JD, Craft RM, LeResche L, etal. Studying sex and gender differences in pain and analgesia: a consensus report. Pain. 2007; 132 Suppl 1:S26-S45.
97. Mogil JS, Chanda ML. The case for the inclusion of female subjects in basic science studies of pain. Pain. 2005;117(1-2):1-5.
98. Rice AS, Cimino-Brown D, Eisenach JC, etal. Animal models and the prediction of efficacy in clinical trials of analgesic drugs: a critical appraisal and call for uniform reporting standards. Pain. 2008;139(2): 243-247.
99. Khalifa MM, Abdelbaky NA. Synthesis of new imidazolyl acetic acid derivatives with anti-inflammatory and analgesic activities. Arch Pharm Res. 2008;31(4):419-423.
100. Munoz J, Navarro C, Noriega V, etal. Synergism between COX-3inhibitors in two animal models of pain. Inflammopharmacology. 2010;18(2):65-71.
101. Lam FF, Ng ES. Substance P and glutamate receptor antagonists improve the anti-arthritic actions of dexamethasone in rats. Br J Pharmacol. 2010;159(4):958-969.